STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Elekta (STO:EKTAB)) will publish its interim report for May-July 2015/16 on September 1, as per:
· The report will be published at 07:30 CET.
· Elekta will host a telephone conference at 10:00-11:00 CET with Tomas Puusepp, President and CEO and Håkan Bergström, CFO.
To take part in the conference call, please dial in about five minutes in advance.
· UK dial-in number: +44 (0) 203 428 14 13
· US dial-in number: +1 855 753 22 36
· Swedish dial-in number: +46 (0)8 566 426 92
The telephone conference will also be broadcasted live online, through the following link (however, please call in also in order to ask questions): http://event.onlineseminarsolutions.com/r.htm?e=1032100&s=1&k=32CB2CD1246774C0E07CA0A5018AF47C
# # #
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.
This information was brought to you by Cision http://news.cision.com